AMBIT BIOSCIENCES CORP
DelistedCIK 1131543fmd_1RY7BW2R80XN0ZNV5YVPHVWYF1Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2011 to Jun 30, 2014, 10 periods
| Line item | FY2011 | FY2012 | FY2013 |
|---|---|---|---|
| Research and development | 51 | 37 | 26 |
| Total operating expenses | 58 | 41 | 34 |
| Operating income | (34) | (23) | (7) |
| Interest expense | 5 | 2 | 0 |
| Other non-operating income (expense) | (4) | (4) | (4) |
| Income before taxes | (37) | (27) | (11) |
| Income tax expense | – | (0) | (0) |
| Net income from continuing operations | (37) | (27) | (11) |
| Net income | (38) | (27) | (11) |
| Net income to common shareholders | (35) | (31) | (13) |